Shishir Gadam
Chief Tech/Sci/R&D Officer at CARGO THERAPEUTICS, INC.
Net worth: 538 894 $ as of 30/04/2024
Profile
Shishir Gadam is currently a Member at Roche Group and the Chief Technical Officer at Cargo Therapeutics, Inc. He previously worked as the VP-Global Cell Therapy Manufacturing Science at Juno Therapeutics, Inc. Gadam holds a doctorate degree from Rensselaer Polytechnic Institute, a graduate degree from West Virginia University, and an undergraduate degree from the University of Mumbai.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
CARGO THERAPEUTICS, INC.
0.07% | 01/03/2024 | 29,480 ( 0.07% ) | 538 894 $ | 30/04/2024 |
Shishir Gadam active positions
| Companies | Position | Start |
|---|---|---|
| CARGO THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 01/01/2022 |
Roche Group
 Roche Group Real Estate DevelopmentFinance Roche Group manages real estate properties. The company designs, develops and constructs residential, commercial and industrial properties. It also provides property management services. The company is headquartered in Basel, Switzerland. | Corporate Officer/Principal | - |
Former positions of Shishir Gadam
| Companies | Position | End |
|---|---|---|
| JUNO THERAPEUTICS INC | Corporate Officer/Principal | - |
Training of Shishir Gadam
| Rensselaer Polytechnic Institute | Doctorate Degree |
| West Virginia University | Graduate Degree |
| University of Mumbai | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| CARGO THERAPEUTICS, INC. | Health Technology |
| Private companies | 2 |
|---|---|
Juno Therapeutics, Inc.
 Juno Therapeutics, Inc. BiotechnologyHealth Technology Juno Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of innovative cellular immunotherapy for the treatment of cancer. It offers platforms which includes chimeric antigen receptors and T-cell receptors. The company was founded by Hans Edgar Bishop, Lawrence Corey, Richard D. Klausner, Stan Riddell, Isabelle Riviere, and Robert Taylor Nelsen on August 5, 2013 and is headquartered in Seattle, WA. | Health Technology |
Roche Group
Roche Group Real Estate DevelopmentFinance Roche Group manages real estate properties. The company designs, develops and constructs residential, commercial and industrial properties. It also provides property management services. The company is headquartered in Basel, Switzerland. | Finance |
- Stock Market
- Insiders
- Shishir Gadam
